Skip to main content
. 2019 Feb 28;26(5):541–551. doi: 10.1111/jvh.13063

Figure 3.

Figure 3

Observed and predicted HCV antibody prevalence in people who inject drugs. Data from the Unlinked Anonymous Monitoring survey 2000‐2016 split into four groups of year started injecting. Posterior medians and 95% credible intervals for HCV prevalence under the base model